| 000 | 03013nam a22003855i 4500 | ||
|---|---|---|---|
| 001 | 86444 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040559.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 160429s2016 gw a s 001 0 eng d | ||
| 020 | _a9783662470817 | ||
| 024 | 7 |
_a10.1007/978-3-662-47081-7 _2doi |
|
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aRC280.S5 _b2016 EB |
|
| 082 | 0 | 4 | _a616.5 |
| 245 | 0 | 0 |
_aHigh-Risk Cutaneous Squamous Cell Carcinoma : _bA Practical Guide for Patient Management _cedited by Chrysalyne D Schmults |
| 264 | 1 |
_aBerlin, Heidelberg _bSpringer Berlin Heidelberg _c2016 |
|
| 300 |
_a1 recurso en línea (XII, 255 p.) _b35 ilustraciones, 32 ilustraciones en color |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _a1. Introduction -- 2. Defining the problem of high-risk SCC: Epidemiology and Outcomes of SCC/Scope of The Problem -- 3. The Evidence For Clinical and Histologic Risk Predictors -- 4. Tumor Staging Systems and Prognostic Stratification -- 5. The scienceof SCC: Molecular/Genetic Underpinnings of Tumorormation/Progression/Metastasis/Immunosurveillance -- 6. Management: Management of Patients With Multiple Sccs/Field Cancerization -- 7. Management of High-Risk Primary Tumors -- 8. Management of Extensive Local Recurrence/In-Transit Metastasis -- 9. Management of Nodal Metastases -- 10. Management of Widely Metastatic and Unresectable Disease. | |
| 520 | 3 | _aThis book is a cutting-edge resource that provides clinicians with the up-to-date practical knowledge required in order to manage SCC patients optimally. It summarizes newly available information relating to the definition of high-risk SCC, its pathophysiologic underpinnings, and its management. New prognostic information and staging systems are summarized that enable high-risk tumors to be defined more precisely than ever before. Many helpful tips are provided on the practical management of challenging cases, including multiple tumors/field cancerization, high-risk tumors, nodal metastases, and unresectable disease. The authors are all acknowledged experts in the emerging field of high-risk and advanced SCC. | |
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 650 | 7 |
_aPiel _xTumores _9174351 _0comprobar BNE19901182798 _2embne |
|
| 650 | 7 |
_aOncología _0comprobar BNE19900969554 _2embne _9139207 |
|
| 700 | 1 |
_aSchmults, Chrysalyne D. _eeditor literario _9100148 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-662-47081-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9783662470817 | ||
| 907 |
_a.b12957227 _b10-10-17 _c21-11-16 |
||
| 988 | _aSpringer_Medicine_2016 | ||
| 998 |
_am _a_alco _a_vill _b23-09-17 _cm _dz _ei _feng _ggw _h0 |
||
| 945 |
_aRC280.S5 H54 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11599029 _z06-04-17 |
||
| 999 |
_c86444 _d86444 _x1 |
||